Shares of LifeVantage Co. (NASDAQ:LFVN – Get Rating) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.75 and traded as high as $4.50. LifeVantage shares last traded at $4.06, with a volume of 110,428 shares changing hands.
Analyst Ratings Changes
Separately, StockNews.com started coverage on LifeVantage in a research note on Thursday. They issued a “strong-buy” rating on the stock.
LifeVantage Stock Performance
The stock has a 50 day moving average of $3.66 and a two-hundred day moving average of $3.76. The firm has a market capitalization of $58.37 million, a P/E ratio of -76.00 and a beta of 1.09.
LifeVantage Increases Dividend
Institutional Investors Weigh In On LifeVantage
A number of institutional investors and hedge funds have recently made changes to their positions in the company. American Century Companies Inc. increased its holdings in LifeVantage by 30.3% in the first quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares during the last quarter. BlackRock Inc. increased its holdings in LifeVantage by 10.5% in the first quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock valued at $1,188,000 after purchasing an additional 23,788 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in LifeVantage by 4.6% in the first quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock valued at $1,293,000 after purchasing an additional 11,964 shares during the last quarter. State Street Corp increased its holdings in LifeVantage by 7.6% in the first quarter. State Street Corp now owns 46,191 shares of the company’s stock valued at $220,000 after purchasing an additional 3,281 shares during the last quarter. Finally, EP Wealth Advisors LLC bought a new stake in LifeVantage in the first quarter valued at about $234,000. Institutional investors own 29.69% of the company’s stock.
LifeVantage Company Profile
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.